Buy Aprezo : Apremilast 30 mg Tablets Online

Description

1. Composition:

• Apremilast: Aprezo tablets contain apremilast as the active pharmaceutical ingredient. Apremilast is a small molecule inhibitor of phosphodiesterase 4 (PDE4), an enzyme involved in the inflammatory process. It is indicated for the treatment of certain inflammatory diseases, including psoriatic arthritis and plaque psoriasis.

2. Indications:

• Psoriatic Arthritis: Aprezo is indicated for the treatment of active psoriatic arthritis in adults, to reduce signs and symptoms of the disease and improve physical function.
• Plaque Psoriasis: Aprezo is also indicated for the treatment of moderate to severe plaque psoriasis in patients who are candidates for phototherapy or systemic therapy.

3. Dosage and Administration:

• The recommended dosage of Aprezo for psoriatic arthritis and plaque psoriasis is usually one tablet (30 mg) taken orally twice daily.
• Tablets should be swallowed whole with a glass of water, with or without food.
• Dosage adjustments may be necessary based on individual patient factors such as disease severity and response to treatment.

4. Effectiveness:

• Aprezo has been shown to be effective in reducing the signs and symptoms of psoriatic arthritis and plaque psoriasis, including joint pain, swelling, and skin lesions.
• Clinical studies have demonstrated improvements in physical function and quality of life in patients treated with apremilast.

5. Safety Profile:

• Aprezo is generally well-tolerated when used as prescribed. Common side effects may include diarrhea, nausea, headache, and upper respiratory tract infection.
• Serious side effects such as depression, suicidal ideation, and weight loss may occur but are rare.
• Patients should be monitored regularly for signs of adverse reactions, including changes in mood, behavior, and gastrointestinal symptoms.

6. Contraindications:

• Aprezo is contraindicated in patients with a known hypersensitivity to apremilast or any of the excipients in the formulation.
• It should not be used in patients with severe renal impairment or moderate to severe hepatic impairment.
• Aprezo is not recommended for use in pregnant or breastfeeding women due to limited data on its safety during pregnancy and lactation.

7. Precautions:

• Aprezo should be used with caution in patients with a history of depression, suicidal thoughts, or psychiatric disorders.
• It should be avoided in patients with a history of alcohol abuse or liver disease, as well as in patients with a predisposition to gastrointestinal disorders.
• Patients should be advised to avoid excessive alcohol consumption while taking Aprezo.

8. Storage:

• Aprezo tablets should be stored at room temperature (15°C to 30°C) in a dry place, away from moisture and heat.
• Keep the medication out of reach of children and pets.

Aprezo tablets, containing apremilast as the active ingredient, provide an effective treatment option for patients with psoriatic arthritis and plaque psoriasis. Treatment should be initiated and supervised by a qualified healthcare professional, and patients should be closely monitored for both efficacy and safety throughout the treatment course.